Is Cochlear Limited a Sell at today's share price?

Cochlear Limited's (ASX:COH) share price has soared more than 30% in the past six months

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cochlear Limited (ASX: COH) has seen its share price rise 33% in the past six months and more than 50% since September 2015 to around $124 currently.

But has it risen too far too fast and could we see a pullback?

Based on consensus earnings expectations of a net profit of around $190 million, Cochlear's shares are currently trading on a prospective P/E ratio of roughly 37x. And that's at the top end of management's guidance.

That's also expensive in anyone's language – although nowhere near Domino's Pizza Enterprises Ltd (ASX: DMP) nosebleed P/E of 71x 2016 financial year (FY16) results.

By comparison, CSL Limited (ASX: CSL) – arguably one of the best stocks on the ASX (if not the best) trades on a relatively conservative P/E ratio of 29x.

However, investors should not forget that a P/E ratio is relative. A company growing net profit and earnings at 32% over the previous year – like Cochlear did in the first half – deserves a premium P/E ratio.

In the first half of FY16, Cochlear saw sales revenue up 32% (16% in constant currency) and net profit up the same rate to $94 million. Growth of 26% in cochlear units was the main driver of rising revenues and after 3 steady years of unit sales, 2016 could see a substantial jump in the number of hearing implants sold.

Additional good news comes in the form of growing bone-anchored hearing systems, and the increasing base number of hearing aid recipients spending more on accessories and upgrades.

Cochlear is also growing its earnings before interest, tax (EBIT) margins – which rose from 22.9% to 23.5% in the first half of FY16. That may not seem like much but does indicate the company has some pricing power.

However, the company did warn of a number of risks that could see the company miss its guidance (see picture below). US seasonality, the majority of China tender units delivered in the first half, increased investment in the second half and a full year forecast exchange rate of US 72 cents. With the US dollar currently at 75.2 US cents and averaging around US73.7 cents, that will certainly create some friction against the company's target.

Cochlear FY16 Outlook
Source: Cochlear Presentation

 

Foolish takeaway

Given the company's own forecasts and the above potential headwinds suggests Cochlear will miss analysts' expectations of a net profit near $190 million. That could see the share price marked down heavily next month when Cochlear reports its full year results.

That's one of the dangers of buying shares at an expensive price – like Cochlear's share price today.

Motley Fool writer/analyst Mike King owns shares in Cochlear and CSL LImited. You can follow Mike on Twitter @TMFKinga The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »